Viking Therapeutics Inc. (VKTX)
NASDAQ: VKTX
· Real-Time Price · USD
40.04
-0.20 (-0.50%)
At close: Aug 15, 2025, 3:59 PM
40.74
1.75%
After-hours: Aug 15, 2025, 07:57 PM EDT
Viking Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | 436K | 436K | 436K | 436K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 75K | 149K | 223K | 296K | 294K | 292K | 290K | 359K | 286K | 291K | 295K | 228K | 301K | 296K | 220K | 145K | 72K |
Gross Profit | -87K | -162K | -236K | 126K | 140K | 142K | 144K | -290K | -359K | -286K | -291K | -295K | -228K | -301K | -296K | -220K | -145K | -72K |
Operating Income | -212.84M | -172.32M | -150.92M | -133.97M | -124.68M | -114.36M | -100.83M | -91.83M | -80.76M | -74.65M | -70.36M | -62.58M | -59.79M | -57.7M | -55.68M | -54.44M | -50.88M | -45.94M |
Interest Income | 22.38M | 34.2M | 40.94M | 34.8M | 28M | 20.73M | 15.02M | 11.05M | 6.76M | 2.47M | 1.59M | 1.02M | 691K | 619K | 704K | 858K | 1.31M | 2.17M |
Pretax Income | -171.55M | -128.24M | -109.96M | -99.15M | -96.75M | -93.72M | -85.89M | -80.85M | -74.09M | -72.3M | -68.87M | -61.66M | -59.13M | -57.08M | -54.99M | -53.58M | -49.63M | -43.82M |
Net Income | -171.55M | -128.24M | -109.96M | -99.15M | -96.75M | -93.72M | -84.89M | -79.12M | -71.94M | -70.14M | -67.58M | -61.1M | -58.99M | -56.94M | -54.99M | -53.58M | -49.63M | -43.82M |
Selling & General & Admin | 57.52M | 53.31M | 49.2M | 42.73M | 37.85M | 37.46M | 37.02M | 32.34M | 27.69M | 21.96M | 16.12M | 14.68M | 13.05M | 11.7M | 10.7M | 10.26M | 10.37M | 10.46M |
Research & Development | 155.32M | 118.93M | 101.64M | 91.16M | 86.75M | 76.9M | 63.81M | 59.48M | 53.06M | 52.69M | 54.23M | 47.9M | 46.74M | 46M | 44.98M | 44.18M | 40.5M | 35.48M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 212.84M | 172.24M | 150.85M | 133.89M | 124.6M | 114.36M | 100.83M | 91.83M | 80.76M | 74.65M | 70.36M | 62.58M | 59.79M | 57.7M | 55.68M | 54.44M | 50.88M | 45.94M |
Interest Expense | 48K | 66K | 94K | 96K | 74K | 88K | 88K | 70K | 95K | 75K | 59K | 63K | 36K | 45K | 54K | 63K | 83K | 82K |
Selling & Marketing Expenses | n/a | -75K | -75K | -75K | -75K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 138.26M | 172.32M | 150.92M | 133.97M | 124.68M | 114.36M | 100.83M | 91.83M | 80.76M | 74.65M | 70.36M | 62.58M | 59.79M | 57.7M | 55.68M | 54.44M | 50.88M | 45.94M |
Income Tax Expense | n/a | n/a | 30.72K | 30.72K | -42.28K | -115.28K | -1.15M | -1.88M | -2.23M | -2.15M | -1.29M | -565K | -142K | -142K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 112.13M | 112.07M | 111.34M | 110.91M | 110.39M | 103.46M | 100.11M | 99.85M | 99.01M | 78.35M | 76.59M | 76.5M | 77.03M | 77.41M | 76.91M | 78.01M | 77.9M | 74.78M |
Shares Outstanding (Diluted) | 112.13M | 112.07M | 111.34M | 110.91M | 110.39M | 103.46M | 100.11M | 99.85M | 99.01M | 78.35M | 76.59M | 76.51M | 77.03M | 77.41M | 76.91M | 78.01M | 77.9M | 74.78M |
EPS (Basic) | -1.53 | -1.15 | -1 | -0.93 | -0.94 | -0.93 | -0.91 | -0.91 | -0.88 | -0.92 | -0.89 | -0.8 | -0.77 | -0.74 | -0.72 | -0.71 | -0.67 | -0.6 |
EPS (Diluted) | -1.53 | -1.15 | -1 | -0.93 | -0.94 | -0.93 | -0.91 | -0.91 | -0.88 | -0.92 | -0.89 | -0.8 | -0.77 | -0.74 | -0.72 | -0.71 | -0.67 | -0.6 |
EBITDA | -212.73M | -172.21M | -150.74M | -133.82M | -124.53M | -114.22M | -100.68M | -91.68M | -80.61M | -74.5M | -70.21M | -62.43M | -59.56M | -57.4M | -55.46M | -54.29M | -50.8M | -44.82M |
EBIT | -203.8M | -172.32M | -150.92M | -133.97M | -124.68M | -114.36M | -100.83M | -91.83M | -80.76M | -74.65M | -70.36M | -62.58M | -59.79M | -57.7M | -55.68M | -54.44M | -50.88M | -44.89M |
Depreciation & Amortization | 197K | 272K | 346K | 310K | 296K | 294K | 292K | 290K | 359K | 328K | 333K | 337K | 270K | 301K | 296K | 291K | 286K | 281K |